Skip to the page

Data / Form D filings / BioLineRx Ltd.

BioLineRx Ltd.: Form D filings

BioLineRx Ltd., a biotechnology company in Modi'In, Israel, filed 3 Form D notices with the SEC between 2020 and 2026. The latest, on September 9, 2026, reports $3.8 million sold of a $3.8 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2 HAMA'AYAN STREET, Modi'In, Israel, 71778
Phone
972-8-642-9100
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Israel
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1498403

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 9, 2026New notice$3,750,000$3,750,0001Aug 27, 2026sec.gov
Jun 10, 2020New notice$9,000,003$9,000,0036May 26, 2020sec.gov
Jun 10, 2020New notice$4,393,000$4,393,0005May 31, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Philip A. SerlinExecutive OfficerChief Executive Officer
Mali ZeeviExecutive OfficerChief Financial Officer
Ella SoraniExecutive OfficerChief Development Officer
Aharon SchwartzDirector
Rami DarDirector
BJ BormannDirector
Raphael HofsteinDirector
Avraham MolchoDirector
Sandra PanemDirector
Shaoyu YanDirector
Gal CohenDirector

Every Form D from the week of Sep 7, 2026 · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what BioLineRx Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.